Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-05-16
2006-05-16
Carlson, Karen Cochrane (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S380000, C514S021800, C514S012200, C435S226000
Reexamination Certificate
active
07045601
ABSTRACT:
The present invention relates to a novel storage-stable formulation for fibrinogen in liquid or viscous liquid form comprising divalent metal ions. The fibrinogen formulation may comprise other conventional formulation ingredients and particularly preferably comprises a complexing agent. The invention further relates to the production and use of the fibrinogen formulation of the invention.
REFERENCES:
patent: 4960757 (1990-10-01), Kumpe et al.
patent: 5099003 (1992-03-01), Kotitschke et al.
patent: 5407671 (1995-04-01), Heimburger et al.
patent: 5411885 (1995-05-01), Marx
patent: 5639940 (1997-06-01), Garner et al.
patent: 5925738 (1999-07-01), Miekka et al.
patent: 5962405 (1999-10-01), Seelich
patent: 6277961 (2001-08-01), Hock et al.
patent: 2001/0033837 (2001-10-01), Metzner et al.
patent: 37 34 923 (1989-01-01), None
patent: 693 03 941 (1994-03-01), None
patent: 100 12 732 (2001-09-01), None
patent: 0 103 196 (1984-03-01), None
patent: 0 253 198 (1988-01-01), None
patent: 0 804 933 (1997-11-01), None
patent: WO 95/23868 (1995-09-01), None
patent: WO 96/30041 (1996-10-01), None
patent: WO 99/56797 (1999-11-01), None
patent: WO 01/48016 (2001-07-01), None
Chabbat, J., Tellier, M., Porte, P., and Steinbuch, M. (1994) Thrombosis Research 76(6): 525-533.
Beriplast® P, Combi-Set 1 ml Package Insert.
Janssen, C. et al., “Conditions for Stabilization and Determination of Activated Factor V,”Thrombosis Research, 5:315-325 (1974).
Takebe, M. et al., “Calcium Ion-Dependent Monoclonal Antibody Against Human Fibrinogen: Preparation, Characterization, and Application to Fibrinogen Purification,”Thrombosis and Haemostasis, 73(4):662-667 (1995).
Clauss, “Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens,”Acta Haemat. 17:237-246 (1957). (English Abstract).
Enssle Karlheinz
Gawantka Volker
Kumpe Gerhardt
Liebing Uwe
Metzner Hubert
Carlson Karen Cochrane
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Tsay Marsha
ZLB BEHRING GmbH
LandOfFree
Storage-stable, liquid fibrinogen formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Storage-stable, liquid fibrinogen formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Storage-stable, liquid fibrinogen formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3613545